Recent Law Review Articles — February 2013

Abortion

Sanger, Carol.  Isaac Marks Memorial Lecture. About abortion: the complications of the category.  54 Ariz. L. Rev. 849-878 (2012).

Scott, T.J.  Note. Why state personhood amendments should be part of the prolife agenda.  6 U. St. Thomas J.L. & Pub. Pol’y. 222-255 (2011).

Silence of the Law (Textbooks). Preface by Teresa Stanton Collett; articles by Prolife Center at the University of St. Thomas, Lynne Marie Kohm, Lynn D. Wardle, Paul Benjamin Linton, Christopher J. Rosko and Leonard J. Nelson, III; bibliography by Valerie Aggerbeck, Deborah Hackerson and Mary Wells.  6 U. St. Thomas J.L. & Pub. Pol’y. 1-221 (2011).

Aging

Hoffman, A. Kimberly and James A. Landon.  Zoning and the aging population: are residential communities zoning elder care out?  44 Urb. Law 629-645 (2012).

Comparative Law

Liebman, Benjamin L.  Malpractice mobs: medical dispute resolution in China.  113 Colum. L. Rev. 181-264 (2013).

Criminal Law

Coe, Jeffrey J.  Note. Seeking a sane solution: reevaluating interests in forcibly medicating criminal defendants to trial competency.  54 Ariz. L. Rev. 1073-1104 (2012).

Embryos

Hoffman, Jessica R.  2012 Schwab Memorial Essay Contest: first-place winner. You say adoption, I say objection: why the word war over embryo disposition is more than just semantics.  46 Fam. L.Q. 397-417 (2012).

Euthanasia

Su, Anne Marie.  Note. Physician assisted suicide: debunking the myths surrounding the elderly, poor, and disabled.  10 Hastings Race & Poverty L.J. 145-176 (2013).

Federal Drug Administration

Ray, Sara J.  Note. Reducing the regulatory role of the FDA: promoting patient autonomy to choose Avastin and other cancer drugs.  45 Conn. L. Rev. 319-355 (2012).

Gender

Green, Jamison.  “If I follow the rules will you make me a man?”: patterns in transsexual validation.  34 U. La Verne L. Rev. 23-87 (2012).

Guardianship

Glen, Kristin Booth.  Changing paradigms: mental capacity, legal capacity, guardianship, and beyond.  44 Colum. Hum. Rts. L. Rev. 93-169 (2012).

Health Records

Grady, Amanda.  Comment. Electronic health records: how the United States can learn from the French Dossier Médical Personnel.  30 Wis. Int’l L.J. 374-400 (2012).

HIV

Heimer, Carol A. and J. Lynn Gazley.  Performing regulation: transcending regulatory ritualism in HIV clinics.  46 Law & Soc’y Rev. 853-887 (2012).

Human Subject Research

Rosko, Christopher J. and Leonard J. Nelson, III.  The Emergency Research Waiver of Consent rule: is it compatible with Catholic teaching?  6 U. St. Thomas J.L. & Pub. Pol’y. 156-205 (2011).

Litigation

Chase-Sosnoff, Emily.  Note. The nursing standard of care in Illinois: rethinking the Wingo exception in the wake of …  (Sullivan v. Edward Hospital, 806 N.E.2d 645, 2004.)  88 Chi.-Kent. L. Rev. 245-284 (2012).

Medicaid

Clark, Steven.  Note. At risk patients and doctors: why increased agency enforcement and private causes of action under the Supremacy Clause are needed to protect Medicaid providers and beneficiaries.  101 Ky. L.J. 183-206 (2012-2013).

Medical Malpractice

Lakdawalla, Darius N. and Seth A. Seabury.  The welfare effects of medical malpractice liability.  32 Int’l Rev. L. & Econ. 356-369 (2012).

Medicare

Kessler, Daniel P.  Reforming Medicare.  65 Tax L. Rev. 811-833 (2012).

Medical Ethics

Aviles, Sarah.  Note. Do you hear what I hear?: the right of prospective parents to use PGD to intentionally implant an embryo containing the gene for deafness.  19 Wm. & Mary J. Women & L. 137-160 (2012).

Military

Parasidis, Efthimios.  Justice and beneficence in military medicine and research.  73 Ohio St. L.J. 723-793 (2012).

Minors

Amberg, Phoebe Anne.  Comment. Protecting kids’ melons: potential liability and enforcement issues with youth concussion laws.  23 Marq. Sports L. Rev. 171-190 (2012).

Organ Transplants

Healy, Kieran and Kimberly D. Krawiec.  Custom, contract, and kidney exchange.  62 Duke L.J. 645-670 (2012).

Patents

Beldiman, Dana.  Patent choke points in the influenza-related medicines industry: can patent pools provide balanced access?  15 Tul. J. Tech. & Intell. Prop. 31-60 (2012).

Shakir, Nida.  Comment. The National Institutes of Health, patents, and the public interest: an expanded rationale of Justice Breyer’s dissent in Stanford v. Roche.  (Bd. Of Trs. Of Leland Stanford Univ. v. Roche Molecular Sys., 131 S. Ct. 2188, 2011.)  17 Marq. Intell. Prop. L. Rev. 143-162 (2013).

The United States Patent and Trademark Office Symposium on Trends in Alternative Dispute Resolution Concerning Intellectual Property Rights Litigation. Foreword by Rachel Wallace; introduction by Thomas D. Barton and James M. Cooper; articles by Jacques de Werra, Kimberley Chen Nobles, Nari Lee, Marcus Norrgård, Barhar H. Malkawi, James M. Cooper, Richard Naiberg, Carlos Ruffinelli and Karin Klempp Franco.  43 Cal. W. Int’l L.J. 1-232 (2012).

Patient Protection and Affordable Care Act

Bowser, Rene.  The Affordable Care Act and beyond: opportunities for advancing health equity and social justice.  10 Hastings Race & Poverty L.J. 69-119 (2013).

Allen, Jessica D.H.  Note. A way forward: establishing financially self-sustaining health-insurance exchanges under the Patient Protection and Affordable Care Act.  98 Iowa L. Rev. 773-808 (2013).

Pharmaceuticals

Beckhaus, Gerrit M.  A new prescription to balance secrecy and disclosure in drug-approval processes.  46 U. Mich. J.L. Reform 135-175 (2012).

Gallman, Robert M.  Comment. Enhancement or recovery? The scientific and legal paradox of performance-enhancing substances.  15 SMU Sci. & Tech. L. Rev. 495-524 (2012).

Khan, Fazal, M.D. and student Justin Holloway.  Verify, then trust: how to legalize off-label drug marketing.  117 Penn St. L. Rev. 407-442 (2012).

Malinowski, Michael J.  Government RX–back to the future in science funding? The next era in drug development.  51 U. Louisville L. Rev. 101-124 (2012).

Roberts, Christopher N.J.  Dynamics of healthcare reform: bitter pills old and new.  45 Vand. J. Transnat’l L. 1341-1380 (2012).

Stackhouse, Timothy P.  Note. Regulators in wackyland: capturing the last of the designer drugs.  54 Ariz. L. Rev. 1105-1137 (2012).

Todd, Adam G.  An enduring oddity: the collateral source rule in the face of tort reform, the Affordable Care Act, and increased subrogation.  43 McGeorge L. Rev. 965-997 (2012).

Pharmacists

Alexander, Nicholas H.  Case note. A new Rx for Arkansas: why the Arkansas Supreme Court should cure its interpretation of the learned intermediary doctrine.  (Kowalski v. Rose Drugs of Dardanelle, Inc., 2011 Ark. 44, __S.W.3d__.)  65 Ark. L. Rev. 929-951 (2012).

RLUIPA

Dalton, Daniel P.  The Religious Land Use and Institutionalized Persons Act: recent developments in RLUIPA’s land use jurisprudence.  44 Urb. Law. 647-665 (2012).

Social Security Disability

Miller, Warnecke and student Rebecca Griffin.  Adjudicating addicts: Social Security disability, the failure to adequately address substance abuse, and proposals for change.  64 Admin. L. Rev. 967-991 (2012).

Stem Cells

Munzer, Stephen R.  How to integrate administrative law and tort law: the regulation of stem cell products.  64 Admin. L. Rev. 743-792 (2012).

Taxation

Gleckman, Howard.  Healthcare and the long-term fiscal outlook.  65 Tax L. Rev. 835-858 (2012).

Monahan, Amy B.  why tax high-cost employer health plans?  65 Tax L. Rev. 749-779 (2012).

Tax Law and Healthcare Reform. Foreword by Deborah H. Schenk; articles by Mark A. Peterson, David Gamage, Lawrence Zelenak, Amy B. Monahan, Mark V. Pauly, Daniel P. Kessler and Howard Gleckman.  65 Tax L. Rev. 619-858 (2012).

Tobacco

Mason, Brian E.  Comment. Tobacco manufacturers and the United States government: ready for battle.  15 SMU Sci. & Tech. L. Rev. 555-587 (2012).

Leave a Reply

Your email address will not be published.